Thermo Fisher Scientific Inc. (NYSE:TMO) entered into a share purchase agreement to acquire Henogen S.A. from Groupe Novasep SAS for approximately €730 million on December 16, 2020. The consideration was paid in cash. Henogen S.A. will become part of the Pharma Services business within the Laboratory Products and Services Segment of Thermo Fisher Scientific Inc. JPMorgan Chase & Co. acted as financial advisor to Groupe Novasep SAS. Cleary Gottlieb Steen & Hamilton LLP acted as legal advisor for Groupe Novasep SAS. Thermo Fisher Scientific Inc. (NYSE:TMO) completed the acquisition of Henogen S.A. from Groupe Novasep SAS on January 15, 2021.